CO 121068
Alternative Names: CO 21068Latest Information Update: 23 Dec 2002
At a glance
- Originator Purdue Pharma
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action GABA A receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 23 Dec 2002 Discontinued - Preclinical for Epilepsy in USA (unspecified route)
- 16 Nov 1999 CoCensys has been acquired by Purdue Pharma
- 07 Apr 1999 New profile